Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
JAAD International|March 5, 2024
Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databasesSteven R Feldman, Rhonda L Bohn, Ran Gao, et al.Pharmacoepidemiology and Drug Safety|June 20, 2012
Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosisPatricia Tennis, Kenneth J Rothman, Rhonda L Bohn, et al.Medical Care|April 30, 2003
Trends in knee magnetic resonance imagingDaniel H Solomon, Jeffrey N Katz, John A Carrino, et al.Journal of Managed Care & Specialty Pharmacy|March 29, 2023
Economic burden related to fistulas or strictures among commercially insured patients with Crohn's disease in the United StatesYanni Fan, Ling Zhang, Monik C Jiménez, et al.Journal of the American Heart Association|August 1, 2013
Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settingsElisabetta Patorno, Robert J Glynn, Sonia Hernandez-Diaz, et al.Pharmacoepidemiology and Drug Safety|April 28, 2012
Validation of a claims-based diagnostic code for Stevens-Johnson syndrome in a commercially insured populationDebra F Eisenberg, Gregory W Daniel, Judith K Jones, et al.ACR Open Rheumatology|September 22, 2021
The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan DatabasesJeffrey R Curtis, Kevin Winthrop, Rhonda L Bohn, et al.Haematologica|November 14, 2024
Challenges associated with access to recently developed hemophilia treatments in routine care: perspectives of healthcare professionalsKarin Berger, Roxy H O'Rourke, Matteo Nicola Dario Di Minno, et al.Drug Safety|February 11, 2014
Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrelJoshua J Gagne, Jeremy A Rassen, Niteesh K Choudhry, et al.Pharmacoepidemiology and Drug Safety|March 17, 2021
Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmicsArlene Tave, Earl Goehring, Vibha Desai, et al.Pageof 4